BioScience and BioMedicine
From Taylor & Francis
Looking to place your work in a leading cell biology journal?
Taylor & Francis has an interdisciplinary cell biology portfolio within BioScience and BioMedicine that's accessible to a worldwide network of authors and readers. Our journals publish high impact research helping to improve health and disease treatment, from biochemistry, drug discovery, protein disorders, artificial cells, tissue engineering and nanomedicine.
We offer hybrid and fully open access publishing options, making it easy to comply with funder mandates and show support for the movement towards open research and open science. Each journal has a peer review process that will validate your research, and eventually publish the best version of your manuscript — a task that only quality editors and peer reviewers can be trusted with. Browse the relevant titles below and find out more about each journal by clicking-through to the Aims & Scope or submit a manuscript.
Open Access Journals
Open Access makes published academic research freely and permanently available online. Anyone, anywhere can access OA research, increasing its visibility and readership. If you choose to publish with us, there is a wide range of open access options available to you. This means you can comply with any funder requirements and ensure your research makes a difference.
Open Access BioMedicine
Artificial Cells, Nanomedicine and Biotechnology
2018 Impact Factor: 4.462 — Covering the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers and tissue engineering. Read more about the Aims & Scope and Editorial Board.
Open Access BioScience
Frontiers in Life Sciences
Open Select ensures researchers can publish open access (OA) in over 2,600 Taylor & Francis journals, ranging across the sciences, social sciences, medicine, technology, engineering, humanities and arts. These hybrid journals publish both OA content and subscription content.
2018 Impact Factor: 3.259 — One of the largest journals in the field, publishing Nobel Prize winning authors. Read research from the 2018 Nobel Prize winners here and read more from our Aims & Scope and Editorial Board.
2018 Impact Factor: 1.550 — Fly is the first international peer-reviewed journal to focus on Drosophilia research. Read more from our Aims & Scope and Editorial Board. Don't miss our Q&A with the new editor, Howy Jacobs.